Whole-brain T2 mapping demonstrates occult abnormalities in focal epilepsy

Neurology

Volumn 64, Issue 2, 2005, Pages 318-325

  Rugg Gunn, F J ^a   Boulby, P A ^a   Symms, M R ^a   Barker, G J ^a,b   Duncan, J S ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c EPILEPSY SOCIETY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN INJURY; BRAIN MALFORMATION; BRAIN MAPPING; CLINICAL ARTICLE; CONTROLLED STUDY; EEG ABNORMALITY; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; FEMALE; FOCAL EPILEPSY; FRONTAL LOBE; HUMAN; MALE; NEOCORTEX; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETRIC TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYMPTOM; TEMPORAL LOBE; WHITE MATTER;

EID: 12544254700     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000149642.93493.F4     Document Type: Article

References (64)

1. Duncan JS. Imaging and epilepsy. Brain 1997;120:376-389.
2. Cascino GD, Jack CR, Parisi JE, et al. MRI in the presurgical evaluation of patients with frontal lobe epilepsy and children with TLE: pathological correlation and prognostic importance. Epilepsy Res 1992;11:51-59.
3. Bastos AC, Comeau RM, Andermann F, et al. Diagnosis of subtle focal dysplastic lesions: curvilinear reformatting from three-dimensional magnetic resonance imaging. Ann Neurol 1999;46:88-94.
4. Bernasconi A, Antel SB, Collins DL, et al. Texture analysis and morphological processing of magnetic resonance imaging assist detection of focal cortical dysplasia in extra-temporal partial epilepsy. Ann Neurol 2001;49:770-775.
5. Kassubek J, Huppertz HJ, Spreer J, Schulze-Bonhage A. Detection and localization of focal cortical dysplasia by voxel-based 3-D MRI analysis. Epilepsia 2002;43:596-602.
6. Bernasconi A, Bernasconi N, Caramanos Z, et al. T2 relaxometry can lateralize mesial temporal lobe epilepsy in patients with normal MRI. Neuroimage 2000;12:739-746.
7. Smith AS, Weinstein MA, Modic MT, et al. Magnetic resonance with marked T2-weighted images: improved demonstration of brain lesions, tumor, and edema. AJR Am J Roentgenol 1985;145:949-955.
8. Jackson GD, Connelly A, Duncan JS, Grunewald RA, Gadian DG. Detection of hippocampal pathology in intractable partial epilepsy: increased sensitivity with quantitative magnetic resonance T2 relaxometry. Neurology 1993;43:1793-1799.
9. Barbosa S, Blumhardt LD, Roberts N, Lock T, Edwards RH. Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the "invisible" lesion load. Magn Res Imag 1994;12:33-42.
10. Woermann FG, Steiner H, Barker GJ, et al. A fast FLAIR dual-echo technique for hippocampal T2 relaxometry: first experiences in patients with temporal lobe epilepsy. J Magn Res Imag 2001;13:547-552.
11. Pell GS, Briellmann RS, Waites AB, Abbott DF, Jackson GD. Voxel-based relaxometry: a new approach for analysis of T2 relaxometry changes in epilepsy. Neuroimage 2004;21:707-713.
12. Rugg-Gunn FJ, Eriksson SH, Symms MR, et al. Diffusion tensor imaging in refractory epilepsy. Lancet 2002;359:1748-1751.
13. Kurki T, Lundbom N, Valtonen S. Tissue characterisation of intracranial tumours: the value of magnetisation transfer and conventional MRI. Neuroradiology 1995;37:515-521.
14. Laakso MP, Partanen K, Soininen H, et al. MR T2 relaxometry in Alzheimer's disease and age-associated memory impairment. Neurobiol Aging 1996;17:535-540.
15. Jacobs MA, Mitsias P, Soltanian-Zadeh H, et al. Multiparametric MRI tissue characterization in clinical stroke with correlation to clinical outcome: part 2. Stroke 2001;32:950-957.
16. Yanagawa Y, Tsushima Y, Tokumaru A, et al. A quantitative analysis of head injury using T2*-weighted gradient-echo imaging. J Trauma 2000;49:272-277.
17. Thurnher MM, Thurnher SA, Fleischmann D, et al. Comparison of T2-weighted and fluid-attenuated inversion-recovery fast spin-echo MR sequences in intracerebral AIDS-associated disease. AJNR Am J Neuroradiol 1997;18:1601-1609.
18. Stevenson VL, Parker GJ, Barker GJ, et al. Variations in T1 and T2 relaxation times of normal appearing white matter and lesions in multiple sclerosis. J Neurol Sci 2000;178:81-87.
19. Deleted in proof.
20. Van Paesschen W, Revesz T, Duncan JS, King MD, Connelly A. Quantitative neuropathology and quantitative magnetic resonance imaging of the hippocampus in temporal lobe epilepsy. Ann Neurol 1997;42:756-766.
21. Briellmann RS, Kalnins RM, Berkovic SF, Jackson GD. Hippocampal pathology in refractory temporal lobe epilepsy: T2-weighted signal change reflects dentate gliosis. Neurology 2002;58:265-271.
22. Bartlett PA, Richardson MP, Duncan JS. Measurement of amygdala T2 relaxation time in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2002;73:753-755.
23. Sisodiya SM. Surgery for malformations of cortical development causing epilepsy. Brain 2000;123:1075-1091.
24. Friston KJ, Ashburner J, Frith JD, Poline JP, Heather JD, Frackowiak RSJ. Spatial registration and normalisation of images. Hum Brain Map 1995;2:165-189.
25. Good CD, Johnsrude I, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains. Neuroimage 2001;14:685-700.
26. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith JD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Map 1995;2:189-210.
27. Friston KJ, Worsley KJ, Frackowiak RSJ, Mazziotta JC, Evans AC. Assessing the significance of focal activations using their spatial extent. Hum Brain Map 1994;1:210-220.
28. Plummer D. A display and analysis tool for medical images. Rev Neuroradiol (Italy) 1992;5:489-495.
29. Whittall KP, MacKay AL, Li DK. Are mono-exponential fits to a few echoes sufficient to determine T2 relaxation for in vivo human brain? Magn Res Med 1999;41:1255-1257.
30. Duncan JS, Bartlett P, Barker GJ. Technique for measuring hippocampal T2 relaxation time. AJNR Am J Neuroradiol 1996;17:1805-1810.
31. 11C-Flumazenil PET in neocortical epilepsy. Neurology 1998;51:485-492.
32. Woermann FG, Free SL, Koepp MJ, Ashburner J, Duncan JS. Voxel-by-voxel comparison of automatically segmented cerebral gray matter - a rater-independent comparison of structural MRI in patients with epilepsy. Neuroimage 1999;10:373-384.
33. Mathur-De Vre R. Biomedical implications of the relaxation behaviour of water related to NMR imaging. Br J Radiol 1984;57:955-976.
34. Fazekas F, Schmidt R, Scheltens P. Pathophysiologic mechanisms in the development of age-related white matter changes of the brain. Dement Geriatr Cogn Disord 1998;9(suppl 1):2-5.
35. Leifer D, Buonanno FS, Richardson EP Jr. Clinicopathologic correlations of cranial magnetic resonance imaging of periventricular white matter. Neurology 1990;40:911-918.
36. Scarpelli M, Salvolini U, Diamanti L, Montironi R, Chiaromoni L, Maricotti M. MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas. Neuroradiology 1994;36:393-398.
37. Woermann FG, Barker GJ, Birnie KD, Meencke HJ, Duncan JS. Regional changes in hippocampal T2 relaxation and volume: a quantitative magnetic resonance imaging study of hippocampal sclerosis. J Neurol Neurosurg Psychiatry 1998;65:656-664.
38. Okujava M, Schulz R, Ebner A, Woermann FG. Measurement of temporal lobe T2 relaxation times using a routine diagnostic MR imaging protocol in epilepsy. Epilepsy Res 2002;48:131-142.
39. Namer IJ, Waydelich R, Armspach JP, Hirsch E, Marescaux C, Grucker D. Contribution of T2 relaxation time mapping in the evaluation of cryptogenic temporal lobe epilepsy. Neuroimage 1998;7:304-313.
40. Adams JH. Head injury. In: Adams JH, Duchen LW, eds. Greenfield's neuropathology. London: Edward Arnold, 1992:106-152.
41. Castillo M, Scatliff JH, Kwock L, et al. Postmortem MR imaging of lobar cerebral infarction with pathologic and in vivo correlation. Radiographics 1996;16:241-250.
42. Jay V, Hwang P, Hoffman HJ, Becker LE, Zielenska M. Intractable seizure disorder associated with chronic herpes infection. HSV1 detection in tissue by the polymerase chain reaction. Childs Nerv Syst 1998; 14:15-20.
43. Vymazal J, Hajek M, Patronas N, et al. The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration. J Magn Res Imag 1995;5:554-560.
44. Manz HJ, Phillips TM, Rowden G, McCullough DC. Unilateral megalencephaly, cerebral cortical dysplasia, neuronal hypertrophy, and heterotopia: cytomorphometric, fluorometric cytochemical, and biochemical analyses. Acta Neuropathol (Berl) 1979;45:97-103.
45. Usui N, Matsuda K, Mihara T, et al. MRI of cortical dysplasia - correlation with pathological findings. Neuroradiology 2001;43:830-837.
46. Marchai G, Andermann F, Tampieri D, et al. Generalized cortical dysplasia manifested by diffusely thick cerebral cortex. Arch Neurol 1989; 46:430-434.
47. Urbach H, Scheffler B, Heinrichsmeier T, et al. Focal cortical dysplasia of Taylor's balloon cell type: a clinicopathological entity with characteristic neuroimaging and histopathological features, and favourable post-surgical outcome. Epilepsia 2002;43:33-40.
48. Barth PG. Disorders of neuronal migration. Can J Neurol Sci 1987;14:1-16.
49. Duong T, De Rosa MJ, Poukens V, Vinters HV, Fisher RS. Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia. Acta Neuropathol (Berl) 1994;87:493-503.
50. Palmini A, Gambardella A, Andermann F, et al. Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann Neurol 1995;37:476-487.
51. Sisodiya SM, Free SL, Stevens JM, Fish DR, Shorvon SD. Widespread cerebral structural changes in patients with cortical dysgenesis and epilepsy. Brain 1995;118:1039-1050.
52. Richardson MP, Koepp MJ, Brooks DJ, Fish DR, Duncan JS. Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: an 11C-flumazenil PET study. Ann Neurol 1996;40:188-198.
53. Eriksson SH, Rugg-Gunn FJ, Symms MR, Barker GJ, Duncan JS. Diffusion tensor imaging in patients with epilepsy and malformations of cortical development. Brain 2001;124:617-626.
54. Cendes F, Li LM, Andermann F, Watson C, et al. Dual pathology and its clinical relevance. Adv Neurol 1999;81:153-164.
55. Zentner J, Hufnagel A, Wolf HK, et al. Surgical treatment of temporal lobe epilepsy: clinical, radiological, and histopathological findings in 178 patients. J Neurol Neurosurg Psychiatry 1995;58:666-673.
56. Theodore WH, Katz D, Kufta C, et al. Pathology of temporal lobe foci: correlation with CT, MRI, and PET. Neurology 1990;40:797-803.
57. Siegel AM, Jobst BC, Thadani VM, et al. Medically intractable, localization-related epilepsy with normal MRI: presurgical evaluation and surgical outcome in 43 patients. Epilepsia 2001;42:883-888.
58. Bothwell S, Meredith GE, Phillips J, et al. Neuronal hypertrophy in the neocortex of patients with temporal lobe epilepsy. J Neurosci 2001;21:4789-4800.
59. Rumbach L, Armspach JP, Gounot D, et al. Nuclear magnetic resonance T2 relaxation times in multiple sclerosis. J Neurol Sci 1991;104:176-181.
60. Allen IV, McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979;41:81-91.
61. Mitchell LA, Jackson GD, Kalnins RM, et al. Anterior temporal abnormality in temporal lobe epilepsy. Neurology 1999;52:327.
62. Meiners LC, Witkamp TD, De Cort GAP, et al. Relevance of temporal lobe white matter changes in hippocampal sclerosis: magnetic resonance imaging and histology. Invest Radiol 1999;34:38-45.
63. Lansberg MG, O'Brien MW, Norbash AM, Moseley ME, Morrell M, Albers GW. MRI abnormalities associated with partial status epilepticus. Neurology 1999;52:1021-1027.
64. Grunewald RA, Jackson GD, Connelly A, Duncan JS. MR detection of hippocampal disease in epilepsy: factors influencing T2 relaxation time. AJNR Am J Neuroradiol 1994;15:1149-1156.